• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vaccination against H9N2 avian influenza virus reduces bronchus-associated lymphoid tissue formation in cynomolgus macaques after intranasal virus cha

tetano

Editor, Senior Moderator
Pathol Int. 2016 Dec;66(12):678-686. doi: 10.1111/pin.12472. Epub 2016 Nov 6.
[h=1]Vaccination against H9N2 avian influenza virus reduces bronchus-associated lymphoid tissue formation in cynomolgus macaques after intranasal virus challenge infection.[/h] Nakayama M[SUP]1[/SUP], Ozaki H[SUP]2[/SUP], Itoh Y[SUP]1[/SUP], Soda K[SUP]2[/SUP], Ishigaki H[SUP]1[/SUP], Okamatsu M[SUP]3[/SUP], Sakoda Y[SUP]3,[/SUP][SUP]4[/SUP], Park CH[SUP]5[/SUP], Tsuchiya H[SUP]6[/SUP], Kida H[SUP]3,[/SUP][SUP]4,[/SUP][SUP]7[/SUP], Ogasawara K[SUP]1,[/SUP][SUP]6[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] H9N2 avian influenza virus causes sporadic human infection. Since humans do not possess acquired immunity specific to this virus, we examined the pathogenicity of an H9N2 virus isolated from a human and then analyzed protective effects of a vaccine in cynomolgus macaques. After intranasal challenge with A/Hong Kong/1073/1999 (H9N2) (HK1073) isolated from a human patient, viruses were isolated from nasal and tracheal swabs in unvaccinated macaques with mild fever and body weight loss. A formalin-inactivated H9N2 whole particle vaccine derived from our virus library was subcutaneously inoculated to macaques. Vaccination induced viral antigen-specific IgG and neutralization activity in sera. After intranasal challenge with H9N2, the virus was detected only the day after inoculation in the vaccinated macaques. Without vaccination, many bronchus-associated lymphoid tissues (BALTs) were formed in the lungs after infection, whereas the numbers of BALTs were smaller and the cytokine responses were weaker in the vaccinated macaques than those in the unvaccinated macaques. These findings indicate that the H9N2 avian influenza virus HK1073 is pathogenic in primates but seems to cause milder symptoms than does H7N9 influenza virus as found in our previous studies and that a formalin-inactivated H9N2 whole particle vaccine induces protective immunity against H9N2 virus.
? 2016 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.


[h=4]KEYWORDS:[/h] BALT; H9N2 influenza virus; non-human primate; vaccine; virus library

PMID: 27910264 DOI: 10.1111/pin.12472
[PubMed - in process]
 
Back
Top Bottom